Impact of early initiation of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with acute coronary syndrome: A systematic review meta-analysis
CONCLUSION: PCSK9i are highly effective in early reduction of LDL-C along with reduction of early hospital readmissions post-ACS.PMID:37777180 | DOI:10.1016/j.ihj.2023.09.005
Source: Indian Heart J - Category: Cardiology Authors: Lakshmi Nagendra Kunal Mahajan Gunjan Gupta Deep Dutta Source Type: research
More News: Cardiology | Cholesterol | Databases & Libraries | Heart | India Health | PET Scan | Study